WO2005023770A1 - Salicylic acid derivatives, process for production thereof and disease controllers for agricultural and horticultural use - Google Patents

Salicylic acid derivatives, process for production thereof and disease controllers for agricultural and horticultural use Download PDF

Info

Publication number
WO2005023770A1
WO2005023770A1 PCT/JP2004/012721 JP2004012721W WO2005023770A1 WO 2005023770 A1 WO2005023770 A1 WO 2005023770A1 JP 2004012721 W JP2004012721 W JP 2004012721W WO 2005023770 A1 WO2005023770 A1 WO 2005023770A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
salicylic acid
lower alkyl
formula
alkyl group
Prior art date
Application number
PCT/JP2004/012721
Other languages
French (fr)
Japanese (ja)
Inventor
Tsumoru Watanabe
Nobuyuki Araki
Masato Arahira
Yuichi Kokaji
Original Assignee
Kureha Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corporation filed Critical Kureha Corporation
Priority to JP2005513659A priority Critical patent/JP4655932B2/en
Publication of WO2005023770A1 publication Critical patent/WO2005023770A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals

Definitions

  • Salicylic acid derivative method for producing the same, and agricultural and horticultural disease controlling agent
  • the present invention relates to a salicylic acid derivative, a method for producing the same, and an agricultural and horticultural disease control agent containing the salicylic acid derivative as an active ingredient.
  • Patent Documents 1 and 2 Conventionally, use of a salicylic acid derivative as a fungicide for agricultural and horticultural use has been proposed (Patent Documents 1 and 2).
  • Patent Document 3 Use of 2,6-dichloro-4-pyridinemethanol and its benzoate derivative as an agricultural chemical has been proposed.
  • Patent Document 1 JP-A-8-291110
  • Patent Document 2 JP-A-10-29961
  • Patent Document 3 JP-A-11-171864
  • an object of the present invention is to provide an agricultural and horticultural disease control agent comprising a salicylic acid derivative, a method for producing the same, and a salicylic acid derivative or a salt thereof as an active ingredient.
  • the salicylic acid derivative represented by the formula ( ⁇ ⁇ ⁇ ) is a novel compound, and is a disease control agent for agricultural and horticultural use. As a result, the present invention has been completed.
  • a first gist of the present invention is an agricultural chemical containing a salicylic acid derivative of the following formula ( ⁇ ⁇ ⁇ ) or a salt thereof as an active ingredient.
  • X represents a lower alkyl group, a lower alkoxy group, a lower haloalkyl group or a halogen atom
  • m represents an integer of 0 to 3.
  • R 1 represents a hydrogen atom or a lower alkyl group
  • R 2 represents a hydrogen atom, a hydroxyl group, a halogen atom, a dimethylamino group, a lower alkyl group or a lower haloalkyl group.
  • a second gist of the present invention is to react a 2-hydroxybenzoic acid derivative of the following formula (III) with a substituted benzylnolide of the formula (IV), And a method for producing a substituted salicylic acid of the formula (I), characterized in that the ester moiety is hydrolyzed.
  • X represents a lower alkyl group, a lower alkoxy group, a lower haloalkyl group, or a halogen atom
  • m represents an integer of 0 to 3.
  • R represents a lower alkyl group.
  • R 2 represents a hydrogen atom, a hydroxyl group, a halogen atom, a dimethylamino group, a lower alkyl group or a lower haloalkyl group
  • Y represents a halogen atom.
  • a third aspect of the present invention resides in a salicylic acid derivative of the above formula ( ⁇ ⁇ ⁇ ) or a salt thereof.
  • the salicylic acid derivative of the formula ( ⁇ ⁇ ⁇ ) and a salt thereof are used for controlling agricultural and horticultural diseases.
  • the agricultural and horticultural disease control agent has an excellent disease control effect.
  • the substituents of the salicylic acid derivative ( ⁇ ⁇ ⁇ ) of the present invention include the following preferred substituents Is included.
  • Examples of the lower alkyl group for X include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group and a propyl group.
  • Examples of the lower alkoxy group include methoxy, ethoxy, 1-methylethyloxy, 1 , 1 dimethylethyloxy and propyloxy;
  • a halogen atom includes a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; and a lower haloalkyl group includes a trifluoromethyl group.
  • Preferred integers m are 0 and 1.
  • Examples of the lower alkyl group for R 1 and R include a methyl group, an ethyl group, and a 1-methylethyl group.
  • the halogen atom for R 2 includes a fluorine atom, a chlorine atom, a bromine atom and an iodine atom, and the lower alkyl group includes a methyl group, an ethyl group, a 1-methylethyl group, a propyl group and a 2-methylpropyl group.
  • the lower haloalkyl group includes a trifluoromethyl group.
  • Examples of the salt of the salicylic acid derivative ( ⁇ ⁇ ⁇ ) include salts containing sodium, potassium, copper, or 1-methylethylamine.
  • a lower alkyl group, a lower alkoxy group, or a lower haloalkyl group is preferably a group having a carbon chain of 114 carbon atoms including the exemplified groups.
  • a lower haloalkyl group refers to a group in which one or more hydrogen atoms of a lower alkyl group are substituted with a halogen atom, preferably a fluorine atom.
  • 5-C1 in the compound () -ll) represents a chlorine atom bonded to the 5-position.
  • 3,5-C1 in the compound ( ⁇ -20) indicates that a chlorine atom is bonded to the 3- and 5-positions.
  • the number before the no and the ifen (-) indicates the bonding position
  • the number after the hyphen (-) indicates the number of substituents and the number of substituents when there are two or more substituents of the same type.
  • H in the compound (II 1) indicates that it is unsubstituted. This rule is also used for the substituent Xm.
  • Examples of the diluent used in the production method of the present invention include the following. Water, organic acids such as formic acid, acetic acid, and propionic acid; hydrocarbons such as benzene, toluene, xylene, petroleum ether, pentane, hexane, and heptane; and halogenated hydrocarbons such as methylene chloride, chloroform, and carbon tetrachloride.
  • organic acids such as formic acid, acetic acid, and propionic acid
  • hydrocarbons such as benzene, toluene, xylene, petroleum ether, pentane, hexane, and heptane
  • halogenated hydrocarbons such as methylene chloride, chloroform, and carbon tetrachloride.
  • Alcohols such as methanol, ethanol, isopropanol and t-butanol, ethers such as getyl ether, dimethoxyethane, diisopropyl ether, tetrahydrofuran, diglyme and dioxane, carbon disulfide, acetonitrile, acetone, Ethyl acetate, acetic anhydride, pyridine, dimethylformamide, dimethylacetamide, 1-methyl-2-pyrrolidinone, dimethylsulfoxide, hexamethylphosphoric amide and the like.
  • ethers such as getyl ether, dimethoxyethane, diisopropyl ether, tetrahydrofuran, diglyme and dioxane
  • carbon disulfide acetonitrile
  • acetone Ethyl acetate
  • acetic anhydride pyridine
  • dimethylformamide dimethylacetamide
  • Examples of the base include the following. Alkali metal carbonates such as sodium carbonate, sodium bicarbonate, potassium carbonate and potassium bicarbonate; alkaline earth metal carbonates such as calcium carbonate and barium carbonate; alkalis such as sodium acetate, potassium acetate and sodium propionate Metal carboxylates, alkali metal hydroxides such as sodium hydroxide and potassium hydroxide, alkaline earth metal oxides such as magnesium oxide and calcium oxide, lithium, sodium, potassium, etc.
  • Alkali metal carbonates such as sodium carbonate, sodium bicarbonate, potassium carbonate and potassium bicarbonate
  • alkaline earth metal carbonates such as calcium carbonate and barium carbonate
  • alkalis such as sodium acetate, potassium acetate and sodium propionate
  • Metal carboxylates alkali metal hydroxides such as sodium hydroxide and potassium hydroxide, alkaline earth metal oxides such as magnesium oxide and calcium oxide, lithium, sodium, potassium, etc.
  • Alkali earth metals such as magnesium, magnesium, etc., alkali metal alkoxides such as sodium methoxide, sodium ethoxide, potassium t-butoxide, alkali metal hydrides such as sodium hydride, potassium hydride, methyllithium, ethyllithium, etc.
  • n-Butyllithium ferric Organic metal compounds of alkali metals, such as organic compounds, organic Grignard reagents such as methyl magnesium iodide, ethyl magnesium bromide, n-butyl magnesium bromide, organic metal compounds of alkali metals, and Grignard reagents and copper (I) salts
  • Organic copper compounds, alkali metal amides such as lithium diisopropyl pyramide, ammonia water, benzyltrimethylammonium hydroxide, ammonium hydroxides such as tetramethylammonium hydroxide, methylamamine, etc.
  • Organic amines such as ethylamine, n-propylamine, benzylamine, ethanolamine, dimethylamine, benzylmethylamine, dibenzylamine, triethylamine, triethanolamine and pyridine.
  • the salt of the first transition element used in the production of the metal complex salt of the salicylic acid derivative ( ⁇ ⁇ ⁇ ) includes three types of salts of acetate, hydrochloride, nitrate, and sulfate (hydrochloride, nitrate or sulfate). It is advantageous to use an alkali metal acetate, carbonate or hydroxide at the same time).
  • the acid include inorganic acids such as hydrochloric acid, hydrobromic acid, hydroiodic acid, perchloric acid, nitric acid, and sulfuric acid, and organic acids such as formic acid, acetic acid, butyric acid, and ⁇ -toluenesulfonic acid. .
  • Salicylic acid ester (II) which is a precursor of substituted salicylic acid (I), is prepared by reacting 2-hydroxybenzoic acid derivative ( ⁇ ) with 2,6-dichloro-4-halogenomethyl pyridine (IV) in the presence of a base. It can be advantageously produced in diluents.
  • 2-hydroxybenzoic acid derivative ( ⁇ ) is dissolved in the above-mentioned diluent, and if necessary, in the presence of the above-mentioned base, 2, 6 —Dichloro-4 halogenomethyl pyridine (IV) is usually 0.5-1.5 equivalents, or reverse diluent 2,6-dichloro-4 halogenomethyl pyridine (IV) dissolved in diluent. It is preferable to add 2-hydroxybenzoic acid derivative (III) and a base to react with each other.
  • reaction temperature at this time any temperature up to the freezing point and boiling point of the diluent as a solvent can be applied, but in practice, the reaction is preferably performed at a temperature in the range of 0 to 100 ° C.
  • the reaction time is usually in the range of 110 hours, and it is desirable to carry out the reaction with stirring.
  • the reaction mixture obtained by the reaction was cooled, extracted with an organic solvent such as ethyl acetate, chloroform, and benzene to separate an organic layer, and then the organic layer was washed with water. After drying, the solvent is distilled off under reduced pressure, and the obtained residue is purified, whereby salicylate ( ⁇ ) can be obtained.
  • the purification treatment can be performed by recrystallization or silica gel column chromatography.
  • the hydrolysis of the ester portion of salicylate (II) can be performed as follows.
  • the salicylic acid ester (II) and the alkali metal hydroxide are added to a hydrous alcohol, and the mixture is usually refluxed at 20 to 100 ° C or 20 ° C at the reflux point of the solvent for usually 120 hours.
  • the reaction mixture was acidified, and the precipitate was collected by filtration or the solvent was distilled off. Stir well and filter off insolubles. Then, the filtrate is recrystallized to obtain the substituted salicylic acid (I).
  • the substituted salicylic acid (I) thus obtained has an acidic proton, it can form a salt in which a hydrogen atom is substituted with an appropriate cation.
  • These salts are generally metal salts, especially alkali metal salts, alkaline earth metal salts or complex salts with first transition elements, including copper, or, in some cases, ammonium salts, alkylated ammonium salts or organic salts.
  • a solvent such as, for example, water, methanol or acetone, usually at a temperature of 20-100 ° C.
  • the salicylic acid derivative ( ⁇ ⁇ ⁇ ) of the present invention has an effect of controlling a wide range of plant diseases shown below.
  • rice blast (Pyriculana oryzae), rice sorghum (Cochiiooolus miyaoeanus), rice seedling disease (Gioberella fonduroi), rice small black tooth nucleus; 3 ⁇ 4
  • 3 ⁇ 4 Helminthosponum sigmoideum
  • Disease fungi (Rhizoctonia solani)
  • gray mold disease that causes various crops Botrytis cinerea
  • sclerotium sclerotium (Sclerotinia scierotiorum), sclerophyte (Fusanum oxysporum f.sp. niveum), yuuri vine ( Cucumennum, Fusarium oxysporum f.sp.
  • the compound in order to apply the salicylic acid derivative ( ⁇ ⁇ ⁇ ) as the agricultural and horticultural disease controlling agent as described above, the compound can be used as it is, but usually, together with a formulation auxiliary, a powder, a wettable powder, and a granule are used.
  • Formulations and emulsions are used in various forms.
  • the preparation usually contains 0.1 to 95% by weight, preferably 0.5 to 90% by weight, more preferably 2 to 70% by weight of one or more salicylic acid derivatives ( ⁇ ⁇ ⁇ ).
  • Examples of carriers, diluents, and surfactants used as formulation aids include talc, kaolin, and vein as solid carriers.
  • Liquid, diluents such as water, xylene, toluene, cyclobenzene, cyclohexane, cyclohexanone, dimethylsulfoxide, dimethylformamide, alcohols, etc.
  • Surfactants that can be properly used depending on their effects include polyoxyethylene alkylaryl ether, polyoxyethylene sorbitan monolaurate, etc., and lignin sulfonate as a dispersant.
  • Dibutylnaphthalenesulfonate and the like, and wetting agents include alkylsulfonate, alkylphenolsulfonate and the like.
  • the concentration of the compound of the present invention when used after dilution is preferably in the range of 0.001 to 1.0%.
  • the amount of the compound of the present invention is usually 20 to 5000 g, preferably 50 to 100 g per lha of agricultural and horticultural land such as fields, fields, orchards and greenhouses. Since the concentration and amount of use vary depending on the dosage form, the time of use, the method of use, the place of use, the target crop, and the like, it is of course possible to increase or decrease the amount without being limited to the above range.
  • the compounds of the present invention can be used in combination with other active ingredients, for example, fungicides, insecticides, acaricides, herbicides.
  • the present conjugate contains a carboxylic acid, it can be used in the form of inorganic salts, organic salts or metal complex salts.
  • the NMR ⁇ vector was measured using TMS as an internal standard, and indicated by the following symbols or a combination of these symbols. s: double line, d: double line, t: triple line, q: quadruple line, m: multiple line, b: broad line, dd: double double line, qq: quadruple line
  • Transplant rice (variety: Koshihikari) at the 3 leaf stage into a 1/1 OoWa Wagner pot filled with paddy soil, and after 20 to 35 days, the granules adjusted according to Formulation Example 3 have a predetermined concentration (500 g / 10a) Was applied to the water surface in the same manner. 10 to 20 days after the chemical treatment, a spore suspension of the rice blast fungus formed on the rice disease was sprayed and inoculated, and kept under high humidity in a vinyl tunnel in a glass greenhouse.
  • a predetermined concentration 500 g / 10a
  • control value (1-disease rate in treated area Z disease rate in untreated area) x 100. Table 9 shows the results.
  • Test example 2 ⁇ Effect of controlling wheat powdery mildew (foliage application)>

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)

Abstract

Salicylic acid derivatives represented by the general formula (I·II); a process for the production thereof; and disease controllers for agricultural and horticultural use, containing as the active ingredient the salicylic acid derivatives or salts thereof: (I·II) (wherein X is lower alkyl, lower alkoxy, lower haloalkyl, or halogeno; m is an integer of 0 to 3; when m is 2 or above, X’s may be the same or different from each other; R1 is hydrogen or lower alkyl; and R2 is hydrogen, hydroxyl, halogeno, dimethylamino, lower alkyl, or lower haloalkyl). The salicylic acid derivatives represented by the general formula (I·II) or salts thereof are useful as active ingredients of disease controllers for agricultural and horticultural use, and disease controllers containing the derivatives or the salts exhibit excellent control activities against diseases.

Description

明 細 書  Specification
サリチル酸誘導体、その製造法および農園芸用病害防除剤  Salicylic acid derivative, method for producing the same, and agricultural and horticultural disease controlling agent
技術分野  Technical field
[0001] 本発明は、サリチル酸誘導体、その製造法およびサリチル酸誘導体を有効成分と して含有する農園芸用病害防除剤に関する。  The present invention relates to a salicylic acid derivative, a method for producing the same, and an agricultural and horticultural disease control agent containing the salicylic acid derivative as an active ingredient.
背景技術  Background art
[0002] 従来、サリチル酸誘導体の農園芸用殺菌剤としての使用が提案されている (特許文 献 1及び 2)。  [0002] Conventionally, use of a salicylic acid derivative as a fungicide for agricultural and horticultural use has been proposed (Patent Documents 1 and 2).
[0003] また、 2, 6—ジクロロー 4 ピリジンメタノール及びその安息香酸エステル誘導体の農 薬としての使用が提案されて 、る (特許文献 3)。  [0003] Further, use of 2,6-dichloro-4-pyridinemethanol and its benzoate derivative as an agricultural chemical has been proposed (Patent Document 3).
特許文献 1:特開平 8—291110公報  Patent Document 1: JP-A-8-291110
特許文献 2 :特開平 10— 29961公報  Patent Document 2: JP-A-10-29961
特許文献 3:特開平 11—171864号公報  Patent Document 3: JP-A-11-171864
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0004] 本発明者らは、上記の実情に鑑み、人畜に対する毒性が低ぐ取り扱い上での安 全性が高ぐ且つ、広汎な植物病害に対して優れた防除効果を示す農園芸用病害 防除剤を開発するために、下記の式 (I · II)のサリチル酸誘導体およびその塩を合成 し、それらの病害防除効果の検討を行った。したがって、本発明の目的は、サリチル 酸誘導体、その製造方法およびサリチル酸誘導体またはその塩を有効成分とする農 園芸用病害防除剤を提供することにある。  [0004] In view of the above circumstances, the present inventors have developed agricultural and horticultural diseases which exhibit low toxicity to humans and animals, high safety in handling, and excellent control effects on a wide range of plant diseases. In order to develop a control agent, salicylic acid derivatives of the following formulas (I and II) and their salts were synthesized and their disease control effects were examined. Accordingly, an object of the present invention is to provide an agricultural and horticultural disease control agent comprising a salicylic acid derivative, a method for producing the same, and a salicylic acid derivative or a salt thereof as an active ingredient.
課題を解決するための手段  Means for solving the problem
[0005] 本発明者らは、カゝかる課題を解決するため鋭意研究を重ねた結果、式 (Ι·Π)で示さ れるサリチル酸誘導体が新規ィ匕合物であり、農園芸用病害防除剤として優れている ことを見出し、本発明の完成に至ったものである。  [0005] The inventors of the present invention have conducted intensive studies in order to solve the problem, and as a result, the salicylic acid derivative represented by the formula (Ι · Π) is a novel compound, and is a disease control agent for agricultural and horticultural use. As a result, the present invention has been completed.
[0006] 本発明は、上記の知見に基づき完成されたものであり、本発明の第 1の要旨は、下 記の式 (Ι·Π)のサリチル酸誘導体またはその塩を有効成分として含有する農園芸用 病害防除剤に存する c [0006] The present invention has been completed based on the above findings, and a first gist of the present invention is an agricultural chemical containing a salicylic acid derivative of the following formula (Ι · Ι) or a salt thereof as an active ingredient. Gardening C in disease control agents
[0007] [化 1]  [0007] [Formula 1]
Figure imgf000004_0001
Figure imgf000004_0001
[0008] 式中、 Xは、低級アルキル基、低級アルコキシ基、低級ハロアルキル基またはハロ ゲン原子を表し、 mは 0から 3の整数を表す。 mが 2以上の時は、 Xは同一もしくは異 なっていてもよい。 R1は、水素原子または低級アルキル基を表し、 R2は、水素原子、 水酸基、ハロゲン原子、ジメチルァミノ基、低級アルキル基または低級ハロアルキル 基を表す。 [0008] In the formula, X represents a lower alkyl group, a lower alkoxy group, a lower haloalkyl group or a halogen atom, and m represents an integer of 0 to 3. When m is 2 or more, X may be the same or different. R 1 represents a hydrogen atom or a lower alkyl group; R 2 represents a hydrogen atom, a hydroxyl group, a halogen atom, a dimethylamino group, a lower alkyl group or a lower haloalkyl group.
[0009] 本発明の第 2の要旨は、下記の式 (III)の 2-ヒドロキシ安息香酸誘導体と式 (IV)の 置換べンジルノヽライドとを反応させることを特徴とする、式 (Π)のサリチル酸エステル の製造方法、及び、エステル部分を加水分解することを特徴とする、式 (I)の置換サリ チル酸の製造方法に存する。 [0009] A second gist of the present invention is to react a 2-hydroxybenzoic acid derivative of the following formula (III) with a substituted benzylnolide of the formula (IV), And a method for producing a substituted salicylic acid of the formula (I), characterized in that the ester moiety is hydrolyzed.
[0010] [化 2] [0010] [Formula 2]
Figure imgf000005_0001
Figure imgf000005_0001
[0011] 式中、 Xは低級アルキル基、低級アルコキシ基、低級ハロアルキル基またはハロゲ ン原子を表し、 mは 0から 3の整数を表す。 mが 2以上の時には、 Xは同一もしくは異 なっていてもよい。 Rは、低級アルキル基を表す。 R2は、水素原子、水酸基、ハロゲン 原子、ジメチルァミノ基、低級アルキル基または低級ハロアルキル基を表し、 Yは、ハ ロゲン原子を表す。 [0011] In the formula, X represents a lower alkyl group, a lower alkoxy group, a lower haloalkyl group, or a halogen atom, and m represents an integer of 0 to 3. When m is 2 or more, X may be the same or different. R represents a lower alkyl group. R 2 represents a hydrogen atom, a hydroxyl group, a halogen atom, a dimethylamino group, a lower alkyl group or a lower haloalkyl group, and Y represents a halogen atom.
[0012] 本発明の第 3の要旨は、上記式 (Ι·Π)のサリチル酸誘導体またはその塩に存する。  A third aspect of the present invention resides in a salicylic acid derivative of the above formula (Ι · Ι) or a salt thereof.
発明の効果  The invention's effect
[0013] 本発明によれば、式 (Ι·Π)のサリチル酸誘導体およびその塩は農園芸用病害防除 剤の有効成分として利用でき、その農園芸用病害防除剤は、優れた病害防除効果 を示す。 According to the present invention, the salicylic acid derivative of the formula (Ι · Π) and a salt thereof are used for controlling agricultural and horticultural diseases. The agricultural and horticultural disease control agent has an excellent disease control effect.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0014] 以下、本発明を詳細に説明する。本発明のサリチル酸誘導体 (Ι·Π) (以下、「本発 明化合物」と略称することがある)の置換基の定義の内、上位概念で示した置換基に は、次の好ましい置換基が包含されている。 Xの低級アルキル基としては、メチル基、 ェチル基、 1-メチルェチル基、 1, 1-ジメチルェチル基およびプロピル基が挙げられ 、低級アルコキシとしては、メトキシ、エトキシ、 1ーメチルェチルォキシ、 1, 1 ジメチ ルェチルォキシ及びプロピルォキシが挙げられ、ハロゲン原子としては、フッ素原子 、塩素原子、臭素原子およびヨウ素原子が挙げられ、低級ハロアルキル基としては、 トリフルォロメチル基が挙げられる。好ましい整数 mは、 0及び 1である。 R1及び Rの低 級アルキル基としては、メチル基、ェチル基および 1-メチルェチル基が挙げらる。 R2 のハロゲン原子としては、フッ素原子、塩素原子、臭素原子およびヨウ素原子が挙げ られ、低級アルキル基としては、メチル基、ェチル基、 1-メチルェチル基、プロピル基 および 2-メチルプロピル基が挙げられ、低級ハロアルキル基としては、トリフルォロメ チル基が挙げられる。サリチル酸誘導体 (Ι·Π)の塩としては、ナトリウム、カリウム、銅 または 1-メチルェチルァミンを含む塩が挙げられる。置換基の定義中、低級アルキ ル基、低級アルコキシ基、低級ハロアルキル基において、例示した基を含む炭素数 1 一 4個の炭素鎖を含む基が好ましい。また、低級ハロアルキル基とは、低級アルキル 基の 1個以上の水素原子がハロゲン原子、好ましくはフッ素原子で置換されている基 を示す。 Hereinafter, the present invention will be described in detail. Among the definitions of the substituents of the salicylic acid derivative (Ι · Π) of the present invention (hereinafter sometimes abbreviated as “the compound of the present invention”), the substituents shown in the general concept include the following preferred substituents Is included. Examples of the lower alkyl group for X include a methyl group, an ethyl group, a 1-methylethyl group, a 1,1-dimethylethyl group and a propyl group.Examples of the lower alkoxy group include methoxy, ethoxy, 1-methylethyloxy, 1 , 1 dimethylethyloxy and propyloxy; a halogen atom includes a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; and a lower haloalkyl group includes a trifluoromethyl group. Preferred integers m are 0 and 1. Examples of the lower alkyl group for R 1 and R include a methyl group, an ethyl group, and a 1-methylethyl group. The halogen atom for R 2 includes a fluorine atom, a chlorine atom, a bromine atom and an iodine atom, and the lower alkyl group includes a methyl group, an ethyl group, a 1-methylethyl group, a propyl group and a 2-methylpropyl group. The lower haloalkyl group includes a trifluoromethyl group. Examples of the salt of the salicylic acid derivative (Ι · Π) include salts containing sodium, potassium, copper, or 1-methylethylamine. In the definition of the substituent, a lower alkyl group, a lower alkoxy group, or a lower haloalkyl group is preferably a group having a carbon chain of 114 carbon atoms including the exemplified groups. Further, a lower haloalkyl group refers to a group in which one or more hydrogen atoms of a lower alkyl group are substituted with a halogen atom, preferably a fluorine atom.
[0015] 次に、サリチル酸誘導体 (Ι·Π)の具体例を表 1に示す。  Next, specific examples of the salicylic acid derivative (Ι · Π) are shown in Table 1.
[0016] [表 1] H HO H S— I [Table 1] H HO HS— I
io-g H H I-I  io-g H H I-I
H ¾D ½-II  H ¾D ½-II
D-S HO ss-ii  D-S HO ss-ii
D D
H IS -II H IS -II
D S Ό 02— II  D S Ό 02— II
1 s 9W 61 -II  1 s 9W 61 -II
ng-ト g H 8T-II  ng-g g H 8T-II
¾-i-g H ΐ-ΙΙ  ¾-i-g H ΐ-ΙΙ
^a-s H 91 -II ^ a-s H 91 -II
- s H ^3 ST— II s I I ト II  -s H ^ 3 ST— II s I I G II
H ει-π  H ει-π
-ig-g H St— π  -ig-g H St— π
IDS H 3W ΐΙ-ΙΙ  IDS H 3W ΐΙ-ΙΙ
d-9 H 01 -II  d-9 H 01 -II
H ng-i 3W 6— II  H ng-i 3W 6— II
H ユ d - u 8— π  H Yu d-u 8— π
H Ζ-ΙΙ  H Ζ-ΙΙ
H 9一 II  H 9-1 II
H S-II  H S-II
H 13 ー π  H 13 ー π
H Λ ε— π  H Λ ε— π
H HO 2-ΙΙ  H HO 2-ΙΙ
H H 9 ト II  H H 9 G II
rax ΐ ¾  rax ΐ ¾
lZLZl0/t00Zdi/∑3d 0んん 0/SOOZ OAV [0017] 表中、化合物 (Π-l l)における 5-C1は、 5位に結合した塩素原子を示す。化合物( Π— 20)における 3, 5-C1は、 3位と 5位とに塩素原子が結合していることを示す。す lZLZl0 / t00Zdi / ∑3d 0n 0 / SOOZ OAV [0017] In the table, 5-C1 in the compound () -ll) represents a chlorine atom bonded to the 5-position. 3,5-C1 in the compound (Π-20) indicates that a chlorine atom is bonded to the 3- and 5-positions. You
2  2
なわち、ノ、ィフン (-)の前の数字は結合位置を示し、ハイフン (-)の後は置換基と、同 種の置換基が 2個以上ある時の個数を示す。化合物(II 1)における Hは、無置換で あることを示す。この規則は、置換基 Xmにおいても使用している。  That is, the number before the no and the ifen (-) indicates the bonding position, and the number after the hyphen (-) indicates the number of substituents and the number of substituents when there are two or more substituents of the same type. H in the compound (II 1) indicates that it is unsubstituted. This rule is also used for the substituent Xm.
[0018] 本発明の製造方法で使用する希釈剤としては、下記のものを例示し得る。水、ギ酸 、酢酸、プロピオン酸などの有機酸、ベンゼン、トルエン、キシレン、石油エーテル、 ペンタン、へキサン、ヘプタン等の炭化水素類、塩化メチレン、クロ口ホルム、四塩化 炭素などのハロゲン化炭化水素類、メタノール、エタノール、イソプロパノール、 tーブ タノール等のアルコール類、ジェチルエーテル、ジメトキシェタン、ジイソプロピルェ 一テル、テトラヒドロフラン、ジグリム、ジォキサン等のエーテル類、二硫化炭素、ァセ トニトリル、アセトン、酢酸ェチル、無水酢酸、ピリジン、ジメチルホルムアミド、ジメチ ルァセトアミド、 1ーメチルー 2—ピロリジノン、ジメチルスルホキシド、へキサメチルホスホ リックアミド等である。 [0018] Examples of the diluent used in the production method of the present invention include the following. Water, organic acids such as formic acid, acetic acid, and propionic acid; hydrocarbons such as benzene, toluene, xylene, petroleum ether, pentane, hexane, and heptane; and halogenated hydrocarbons such as methylene chloride, chloroform, and carbon tetrachloride. Alcohols such as methanol, ethanol, isopropanol and t-butanol, ethers such as getyl ether, dimethoxyethane, diisopropyl ether, tetrahydrofuran, diglyme and dioxane, carbon disulfide, acetonitrile, acetone, Ethyl acetate, acetic anhydride, pyridine, dimethylformamide, dimethylacetamide, 1-methyl-2-pyrrolidinone, dimethylsulfoxide, hexamethylphosphoric amide and the like.
[0019] 塩基としては、次のものを例示できる。炭酸ナトリウム、炭酸水素ナトリウム、炭酸カリ ゥム、炭酸水素カリウム等のアルカリ金属の炭酸塩、炭酸カルシウム、炭酸バリウム等 のアルカリ土類金属の炭酸塩、酢酸ナトリウム、酢酸カリウム、プロピオン酸ナトリウム 等のアルカリ金属のカルボン酸塩、水酸化ナトリウム、水酸ィ匕カリウム等のアルカリ金 属の水酸化物、酸化マグネシウム、酸ィ匕カルシウム等のアルカリ土類金属の酸ィ匕物、 リチウム、ナトリウム、カリウム等のアルカリ金属、マグネシウム等のアルカリ土類金属、 ナトリウムメトキシド、ナトリウムエトキシド、カリウム t ブトキシド等のアルカリ金属のァ ルコキシド、水素化ナトリウム、水素化カリウム等のアルカリ金属水素化合物、メチルリ チウム、ェチルリチウム、 n-ブチルリチウム、フエ-ルリチウム等のアルカリ金属の有機 金属化合物、メチルマグネシウムアイオダイド、ェチルマグネシウムブロマイド、 n-ブ チルマグネシウムブロマイド等の有機グリニャール試薬、アルカリ金属の有機金属化 合物や、グリニャール試薬と銅 (I)塩から調製できる有機銅化合物、リチウムジィソプ 口ピルアミド等のアルカリ金属アミド、アンモニア水、水酸化べンジルトリメチルアンモ ユウム、水酸化テトラメチルアンモ -ゥム等の水酸化アンモウ-ゥム類、メチルァミン、 ェチルァミン、 n-プロピルァミン、ベンジルァミン、エタノールァミン、ジメチルァミン、 ベンジルメチルァミン、ジベンジルァミン、トリエチルァミン、トリエタノールァミン、ピリ ジン等の有機アミン類である。 [0019] Examples of the base include the following. Alkali metal carbonates such as sodium carbonate, sodium bicarbonate, potassium carbonate and potassium bicarbonate; alkaline earth metal carbonates such as calcium carbonate and barium carbonate; alkalis such as sodium acetate, potassium acetate and sodium propionate Metal carboxylates, alkali metal hydroxides such as sodium hydroxide and potassium hydroxide, alkaline earth metal oxides such as magnesium oxide and calcium oxide, lithium, sodium, potassium, etc. Alkali earth metals such as magnesium, magnesium, etc., alkali metal alkoxides such as sodium methoxide, sodium ethoxide, potassium t-butoxide, alkali metal hydrides such as sodium hydride, potassium hydride, methyllithium, ethyllithium, etc. n-Butyllithium, ferric Organic metal compounds of alkali metals, such as organic compounds, organic Grignard reagents such as methyl magnesium iodide, ethyl magnesium bromide, n-butyl magnesium bromide, organic metal compounds of alkali metals, and Grignard reagents and copper (I) salts Organic copper compounds, alkali metal amides such as lithium diisopropyl pyramide, ammonia water, benzyltrimethylammonium hydroxide, ammonium hydroxides such as tetramethylammonium hydroxide, methylamamine, etc. Organic amines such as ethylamine, n-propylamine, benzylamine, ethanolamine, dimethylamine, benzylmethylamine, dibenzylamine, triethylamine, triethanolamine and pyridine.
[0020] サリチル酸誘導体 (Ι·Π)の金属錯塩の製造に使用する第 1遷移元素の塩としては 、酢酸塩、塩酸塩、硝酸塩、硫酸塩 (塩酸塩、硝酸塩または硫酸塩の 3種類の塩を使 用する時には、アルカリ金属の酢酸塩、炭酸塩または水酸化物を同時に使用するの が有利である)が挙げられる。また、酸としては、塩酸、臭化水素酸、ヨウ化水素酸、 過塩素酸、硝酸、硫酸などの無機酸およびギ酸、酢酸、酪酸、 Ρ-トルエンスルホン酸 などの有機酸などを例示し得る。  [0020] The salt of the first transition element used in the production of the metal complex salt of the salicylic acid derivative (Ι · Π) includes three types of salts of acetate, hydrochloride, nitrate, and sulfate (hydrochloride, nitrate or sulfate). It is advantageous to use an alkali metal acetate, carbonate or hydroxide at the same time). Examples of the acid include inorganic acids such as hydrochloric acid, hydrobromic acid, hydroiodic acid, perchloric acid, nitric acid, and sulfuric acid, and organic acids such as formic acid, acetic acid, butyric acid, and Ρ-toluenesulfonic acid. .
[0021] 置換サリチル酸 (I)の前駆体であるサリチル酸エステル (II)は、 2-ヒドロキシ安息香 酸誘導体 (ΠΙ)と 2, 6-ジクロロ- 4-ハロゲノメチルビリジン (IV)とを塩基の存在下、 希釈剤中で有利に製造できる。本発明の製造方法を実施するには、例えば、 2-ヒド ロキシ安息香酸誘導体 (ΠΙ)を前掲の希釈剤に溶かしたものに、必要に応じ、上掲の 塩基の存在下に、 2, 6—ジクロロー 4 ハロゲノメチルビリジン(IV)を通常 0. 5-1. 5 当量カ卩える力、又は、逆〖こ 2, 6—ジクロロー 4 ハロゲノメチルビリジン (IV)を希釈剤に 溶力したものに、 2-ヒドロキシ安息香酸誘導体 (III)と塩基とを加えて反応させるとよ い。この際の反応温度は、溶媒としての上記希釈剤の凝固点力 沸点までの任意の 温度を適用し得るが、実際上は 0— 100°Cの範囲の温度で反応を行うことが好ましい 。また、反応時間は通常 1一 10時間の範囲であって、攪拌下に反応を行うことが望ま しい。上記反応の終了後、反応により得られた反応混合物を冷却した後、酢酸ェチ ル、クロ口ホルム、ベンゼン等の有機溶剤により抽出して有機層を分離し、次いで該 有機層を水洗して乾燥した後、溶媒を減圧下に留去し、得られた残渣を精製処理す ることにより、サリチル酸エステル (Π)を得ることができる。なお、精製処理は、再結晶 またはシリカゲルカラムクロマトグラフィー等に付すことにより行い得る。  [0021] Salicylic acid ester (II), which is a precursor of substituted salicylic acid (I), is prepared by reacting 2-hydroxybenzoic acid derivative (ΠΙ) with 2,6-dichloro-4-halogenomethyl pyridine (IV) in the presence of a base. It can be advantageously produced in diluents. In order to carry out the production method of the present invention, for example, 2-hydroxybenzoic acid derivative (ΠΙ) is dissolved in the above-mentioned diluent, and if necessary, in the presence of the above-mentioned base, 2, 6 —Dichloro-4 halogenomethyl pyridine (IV) is usually 0.5-1.5 equivalents, or reverse diluent 2,6-dichloro-4 halogenomethyl pyridine (IV) dissolved in diluent. It is preferable to add 2-hydroxybenzoic acid derivative (III) and a base to react with each other. As the reaction temperature at this time, any temperature up to the freezing point and boiling point of the diluent as a solvent can be applied, but in practice, the reaction is preferably performed at a temperature in the range of 0 to 100 ° C. The reaction time is usually in the range of 110 hours, and it is desirable to carry out the reaction with stirring. After the completion of the above reaction, the reaction mixture obtained by the reaction was cooled, extracted with an organic solvent such as ethyl acetate, chloroform, and benzene to separate an organic layer, and then the organic layer was washed with water. After drying, the solvent is distilled off under reduced pressure, and the obtained residue is purified, whereby salicylate (Π) can be obtained. The purification treatment can be performed by recrystallization or silica gel column chromatography.
[0022] サリチル酸エステル (II)のエステル部分の加水分解は、次の様にして行うことが出 来る。含水アルコールに、サリチル酸エステル (Π)とアルカリ金属水酸ィ匕物をカ卩えて、 通常 20— 100°C又は 20°C—溶媒の還流点で、通常 1一 20時間還流する。反応後、 反応混合物を酸性にし、析出物を濾取するか、溶媒を留去して、残渣に水を加えて 良くかき混ぜてから、不溶分を濾取する。ついで、濾物を再結晶して、置換サリチル 酸 (I)を得ることが出来る。 [0022] The hydrolysis of the ester portion of salicylate (II) can be performed as follows. The salicylic acid ester (II) and the alkali metal hydroxide are added to a hydrous alcohol, and the mixture is usually refluxed at 20 to 100 ° C or 20 ° C at the reflux point of the solvent for usually 120 hours. After the reaction, the reaction mixture was acidified, and the precipitate was collected by filtration or the solvent was distilled off. Stir well and filter off insolubles. Then, the filtrate is recrystallized to obtain the substituted salicylic acid (I).
[0023] この様にして得られる置換サリチル酸 (I)は酸性プロトンを有するので、水素原子が 適当な陽イオンで置換された塩を形成しうる。これらの塩は、一般に、金属塩、特に アルカリ金属塩、アルカリ土類金属塩または銅を含む第 1遷移元素との錯塩、又は、 場合によっては、アンモニゥム塩、アルキル化アンモ-ゥム塩または有機のアミン塩 であり、そして、好ましくは、例えば、水、メタノール又はアセトンのような溶媒中で通 常 20— 100°Cの温度において製造できる。  [0023] Since the substituted salicylic acid (I) thus obtained has an acidic proton, it can form a salt in which a hydrogen atom is substituted with an appropriate cation. These salts are generally metal salts, especially alkali metal salts, alkaline earth metal salts or complex salts with first transition elements, including copper, or, in some cases, ammonium salts, alkylated ammonium salts or organic salts. And preferably can be prepared in a solvent such as, for example, water, methanol or acetone, usually at a temperature of 20-100 ° C.
[0024] 次に、本発明に係る前記式 (Ι·Π)のサリチル酸誘導体の農園芸用病害防除剤の活 性成分としての有用性について説明する。本発明のサリチル酸誘導体 (Ι·Π)は下記 に示す広汎な植物病害に対して防除効果を呈する。例えば、イネいもち病( Pyriculana oryzae)、ィネこよ f古 ί丙菌 (Cochiiooolus miyaoeanus 、ィ不ば 苗病菌 (Gioberella lujiKuroi)、ィネ小黒歯核; ¾ |¾ (Helminthosponum sigmoideum)、ィ不紋 枯病菌(Rhizoctonia solani)、種々の作物を犯す灰色かび病(Botrytis cinerea)、菌 核 ί丙菌 (Sclerotinia scierotiorum 、スィ力つ 害 (Ιί丙菌 (Fusanum oxysporum f.sp. niveum)、 ユウリつる昔 (Fusarium oxysporum f.sp. cucumennum)、ゥリ類灰そ 病菌 (Colletotrichum lagenarium)、アンサィ褐斑病菌 (Cercospora beticola)、ダイズ 紫斑病菌(Cercospora kikuchii)、モモ灰星病菌 (Sclerotinia cinerea)、リンゴ斑点落 葉 ί丙菌 (Alternaria alternata(mali))、ナン黒斑柄菌 (Alternaria alternata(kikuchiana) ) 、ブド,ノ晚腐病! ¾ (ulomerella cingulata)、 =ユウリベと 3 (Pseudoperonosora cubensis )、トマト疫病 (Phytophthra infestans)、キュゥリ灰色疫病菌 (Phytophthora capsici)、 イネ苗立枯病菌(Pythium aphanidermatum)等である。 Next, the usefulness of the salicylic acid derivative of the formula (II) according to the present invention as an active ingredient of an agricultural and horticultural disease controlling agent will be described. The salicylic acid derivative (Ι · Π) of the present invention has an effect of controlling a wide range of plant diseases shown below. For example, rice blast (Pyriculana oryzae), rice sorghum (Cochiiooolus miyaoeanus), rice seedling disease (Gioberella lujiKuroi), rice small black tooth nucleus; ¾ | ¾ (Helminthosponum sigmoideum), Disease fungi (Rhizoctonia solani), gray mold disease that causes various crops (Botrytis cinerea), sclerotium sclerotium (Sclerotinia scierotiorum), sclerophyte (Fusanum oxysporum f.sp. niveum), yuuri vine ( Cucumennum, Fusarium oxysporum f.sp. cucumennum, Colletotrichum lagenarium, Anthe brown leaf spot (Cercospora beticola), Soybean purple spot (Cercospora kikuchii), Peach leaf spot (Sclerotinia cinerea), Apple spot spot ίhei fungus (Alternaria alternata (mali)), Nan black spotted fungus (Alternaria alternata (kikuchiana)), bud , no rot! ul (ulomerella cingulata), = yuribe and 3 (Pseudoperonosora cubensis), tomato plague (Phytophthra) infestans), cucumber gray plague (Phytophthora capsici), Rice seedling blight fungus (Pythium aphanidermatum).
[0025] サリチル酸誘導体 (Ι·Π)を上述のごとき農園芸用病害防除剤として適用するには、 化合物をそのまま使用することも出来るが、通常は製剤補助剤と共に、粉剤、水和剤 、粒剤、乳剤などの種々の形態に製剤して使用する。このとき製剤中に、 1種または 2 種以上のサリチル酸誘導体 (Ι·Π)が通常 0. 1— 95%重量、好ましくは 0. 5— 90% 重量%、より好ましくは 2— 70重量%含まれる様に製剤する。製剤補助剤として使用 する坦体、希釈剤、界面活性剤を例示すれば、固体坦体として、タルク、カオリン、ベ ンナイト、珪藻土、ホワイトカーボン、クレー等が挙げられ、液体希釈剤として、水、キ シレン、トルエン、クロ口ベンゼン、シクロへキサン、シクロへキサノン、ジメチルスルホ キシド、ジメチルホルムアミド、アルコール等が挙げられ、界面活性剤はその効果によ り使い分けるのがよぐ乳ィ匕剤として、ポリオキシエチレンアルキルァリールエーテル、 ポリオキシエチレンソルビタンモノラウレート等が挙げられ、分散剤として、リグ-ンス ルホン酸塩、ジブチルナフタリンスルホン酸塩などが挙げられ、湿潤剤として、アルキ ルスルホン酸塩、アルキルフエ-ルスルホン酸塩などが挙げられる。上記製剤には、 そのまま使用するものと水などの希釈剤で所定濃度に希釈して使用するものとがある[0025] In order to apply the salicylic acid derivative (農 · Π) as the agricultural and horticultural disease controlling agent as described above, the compound can be used as it is, but usually, together with a formulation auxiliary, a powder, a wettable powder, and a granule are used. Formulations and emulsions are used in various forms. At this time, the preparation usually contains 0.1 to 95% by weight, preferably 0.5 to 90% by weight, more preferably 2 to 70% by weight of one or more salicylic acid derivatives (Ι · Π). Formulated so that Examples of carriers, diluents, and surfactants used as formulation aids include talc, kaolin, and vein as solid carriers. Liquid, diluents such as water, xylene, toluene, cyclobenzene, cyclohexane, cyclohexanone, dimethylsulfoxide, dimethylformamide, alcohols, etc. Surfactants that can be properly used depending on their effects include polyoxyethylene alkylaryl ether, polyoxyethylene sorbitan monolaurate, etc., and lignin sulfonate as a dispersant. , Dibutylnaphthalenesulfonate and the like, and wetting agents include alkylsulfonate, alkylphenolsulfonate and the like. Some of the above preparations are used as is, and others are diluted to a certain concentration with a diluent such as water.
。希釈して使用する時の本発明化合物の濃度は 0. 001—1. 0%の範囲が好ましい 。また、本発明化合物の使用量は畑、田、果樹園、温室などの農園芸地 lha当り、通 常 20— 5000g、好ましくは 50— lOOOgである。これらの使用濃度および使用量は剤 形、使用時期、使用方法、使用場所、対象作物などによっても異なるため、上記の範 囲にこだわることなく増減することは勿論可能である。さらに、本発明化合物は他の有 効成分、例えば、殺菌剤、殺虫剤、殺ダニ剤、除草剤と組み合わせて使用することも できる。因みに、本ィ匕合物はカルボン酸を含有しているので、無機塩類、有機塩類も しくは金属錯塩などの形態でも使用し得る。 . The concentration of the compound of the present invention when used after dilution is preferably in the range of 0.001 to 1.0%. The amount of the compound of the present invention is usually 20 to 5000 g, preferably 50 to 100 g per lha of agricultural and horticultural land such as fields, fields, orchards and greenhouses. Since the concentration and amount of use vary depending on the dosage form, the time of use, the method of use, the place of use, the target crop, and the like, it is of course possible to increase or decrease the amount without being limited to the above range. Furthermore, the compounds of the present invention can be used in combination with other active ingredients, for example, fungicides, insecticides, acaricides, herbicides. Incidentally, since the present conjugate contains a carboxylic acid, it can be used in the form of inorganic salts, organic salts or metal complex salts.
実施例  Example
[0026] 以下、本発明を製造例、製剤例、試験例により更に詳細に説明するが、本発明は、 その要旨を超えない限り、以下の製造例に限定されるものではない。なお、 NMR^ ベクトルは TMSを内部標準にして測定し、次記の記号またはこれらを組み合わせた 記号で示した。 s :—重線、 d:二重線、 t :三重線、 q:四重線、 m:多重線、 b :ブロード ライン、 dd:二重二重線、 qq :四重四重線  Hereinafter, the present invention will be described in more detail with reference to Production Examples, Formulation Examples, and Test Examples, but the present invention is not limited to the following Production Examples as long as the gist is not exceeded. The NMR ^ vector was measured using TMS as an internal standard, and indicated by the following symbols or a combination of these symbols. s: double line, d: double line, t: triple line, q: quadruple line, m: multiple line, b: broad line, dd: double double line, qq: quadruple line
[0027] 製造例 1 :  Production Example 1:
< 6—クロ口— 2— (2, 6—ジクロロー 4 ピリジルメトキシ)安息香酸メチルエステル(ィ匕合 物番号 Π-4)の製造 >  <Preparation of 6-chloro-2— (2,6-dichloro-4pyridylmethoxy) benzoic acid methyl ester (Danizo Compound No. Π-4)>
6 クロ口サリチル酸メチルエステル 0. 93gをアセトン 50mlに溶力し、炭酸カリウム 1 . 35g、 4 クロロメチルー 2, 6—ジクロ口ピリジン 1. lgを加え 8時間加熱還流を行った 。反応終了後、反応液に水を注ぎ、酢酸ェチルで抽出を行った。有機層を水、飽和 食塩水で順次洗浄した後、無水硫酸ナトリウムで乾燥し、溶媒を留去、得られた残渣 をカラムクロマトグラフィー(ヮコ一ゲル C 300 へキサン/酢酸ェチル = 8Z 1 )で処 理して、 目的化合物を 1. 3g得た。この化合物の物性を表 2に示す 0.93 g of methyl salicylic acid methyl ester was dissolved in 50 ml of acetone, and 1.35 g of potassium carbonate and 1. lg of 4-chloromethyl-2,6-dichloromouth pyridine were added, followed by heating under reflux for 8 hours. After completion of the reaction, water was poured into the reaction solution, and extraction was performed with ethyl acetate. Organic layer is saturated with water After successive washing with brine, drying over anhydrous sodium sulfate, the solvent was distilled off, and the resulting residue was subjected to column chromatography (CO-gel C300 hexane / ethyl acetate = 8Z1), 1.3 g of the target compound was obtained. Table 2 shows the physical properties of this compound.
[0028] [表 2] [Table 2]
(1)融点: 141〜142°C (1) Melting point: 141-142 ° C
(2) IR(NaCl法, v ,cm : 3472, 1740, 1592,1480, 1276, 1066  (2) IR (NaCl method, v, cm: 3472, 1740, 1592, 1480, 1276, 1066
(3) NMR(CDC13, δ ,ppm): 3.99 (3H,s),5.09(2H,s))6.78(lH,d,J=8.1Hz), (3) NMR (CDC13, δ, ppm): 3.99 (3H, s), 5.09 (2H, s) ) 6.78 (lH, d, J = 8.1Hz),
7.09(lH,d,J=8.1Hz),7.26〜7.51(3H,m)  7.09 (lH, d, J = 8.1Hz), 7.26 to 7.51 (3H, m)
[0029] 製造例 2 : Production Example 2:
< 2-(2, 6—ジクロロー 4 ピリジルメトキシ) 5 クロ口安息香酸メチルエステル(ィ匕合 物番号 Π-11)の製造 >  <Production of 2- (2,6-dichloro-4-pyridylmethoxy) -5-chlorobenzoic acid methyl ester (I-Danigo Compound No. Π-11)>
無水アセトン 6mlに、 5—クロ口サリチル酸メチルエステル 0. 186gを溶解し、炭酸力 リウム 1. lg、 4ーブロモメチルー 2, 6—ジクロロピリジン 0. 241gを加え、 16時間加熱 還流を行った。反応終了後、反応液に水を加え、酢酸ェチルで抽出した。有機層を 飽和食塩水、水で順次洗浄した後、無水硫酸ナトリウムで乾燥し、次いで減圧下に 溶媒を留去した。得られた残渣をシリカゲルカラムクロマトグラフィーに付して精製し、 目的化合物を 0. 294g得た。この化合物の物性を表 3に示す。  0.186 g of methyl 5-salicylic acid methyl ester was dissolved in 6 ml of anhydrous acetone, 1.1 g of lithium carbonate and 0.241 g of 4-bromomethyl-2,6-dichloropyridine were added, and the mixture was heated under reflux for 16 hours. After the completion of the reaction, water was added to the reaction solution, and extracted with ethyl acetate. The organic layer was washed sequentially with saturated saline and water, dried over anhydrous sodium sulfate, and then the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography to obtain 0.294 g of the desired compound. Table 3 shows the physical properties of this compound.
[0030] [表 3] [Table 3]
(1)融点: 140〜142°C (1) Melting point: 140-142 ° C
(2) IR(NaCl法, v ,cm- : 2908,1700,1606, 1456,1280,1074  (2) IR (NaCl method, v, cm-: 2908,1700,1606, 1456,1280,1074
(3) NMR(CDC13, δ ,ppm): 4.00(3H,s),5.12(2H,s),6.8~7.6(5H,m)17.53(2H,bs) (3) NMR (CDC13, δ, ppm): 4.00 (3H, s), 5.12 (2H, s), 6.8 to 7.6 (5H, m) 1 7.53 (2H, bs)
[0031] 製造例 3 : Production Example 3:
< 2-(2, 6—ジクロロー 4 ピリジルメトキシ)ー6—ヒドロキシ安息香酸(ィ匕合物番号 1-2) の製造 >  <Production of 2- (2,6-dichloro-4-pyridylmethoxy) -6-hydroxybenzoic acid (I-drug No. 1-2)>
窒素気流下、 60%油性水素化ナトリウム 0. 4gを無水へキサンにて洗浄後、無水ジ メチルホルムアミド 100mlに懸濁させた。氷冷攪拌下、 2, 6—ジヒドロキシ安息香酸メ チノレエステノレ 1. 68gをカロえた後、 4ーブロモメチノレー 2, 6—ジクロロピリジン 2. 65gを ジメチルホルムアミド 30mlに溶解した溶液を滴下した。 1時間後、反応温度を徐々に 上げ、温度を 30°C程度に保ちながら 6時間反応させた。反応終了後、反応駅に水を 加え、酢酸ェチルを用いて抽出を行った。有機層を水、飽和食塩水で順次洗浄後、 無水硫酸ナトリウムで乾燥した。溶媒を留去後、得られた残渣をシリカゲルカラムクロ マトグラフィ一に付して精製し、 目的化合物のメチルエステルにあたるサリチル酸エス テル (ィ匕合物番号 Π-3)を 2. 3g得た。この化合物の物性を表 4に示す。 Under a nitrogen stream, 0.4 g of 60% oily sodium hydride was washed with anhydrous hexane, and then suspended in 100 ml of anhydrous dimethylformamide. Under ice-cooling and stirring, 1.68 g of 2,6-dihydroxybenzoic acid methinolate was added, and a solution prepared by dissolving 2.65 g of 4-bromomethinolee 2,6-dichloropyridine in 30 ml of dimethylformamide was added dropwise. After 1 hour, gradually increase the reaction temperature The reaction was performed for 6 hours while maintaining the temperature at about 30 ° C. After completion of the reaction, water was added to the reaction station, and extraction was performed using ethyl acetate. The organic layer was washed successively with water and saturated saline, and then dried over anhydrous sodium sulfate. After evaporating the solvent, the obtained residue was purified by silica gel column chromatography to obtain 2.3 g of a salicylic acid ester (Danigari Compound No. III-3) which is a methyl ester of the target compound. Table 4 shows the physical properties of this compound.
[0032] [表 4] [0032] [Table 4]
(丄)融点: 136~137°C (丄) Melting point: 136 ~ 137 ° C
(2) IR(NaCl法, v ,cm-り: 1660,1592,1464,1260, 1104  (2) IR (NaCl method, v, cm-R: 1660,1592,1464,1260,1104
(3) NMR(CDC13, δ ,ppm): 4.07(3H,s),5.17(2H,s),6.48(lH,d,J=8.0Hz),  (3) NMR (CDC13, δ, ppm): 4.07 (3H, s), 5.17 (2H, s), 6.48 (lH, d, J = 8.0 Hz),
6.67(lH,d) 8.0Hz),7.37 iH,t,J=8.0Hz), 7.53(2H,bs), 11.2(lH,bs) 6.67 (lH, d ) 8.0Hz), 7.37 iH, t, J = 8.0Hz), 7.53 (2H, bs), 11.2 (lH, bs)
[0033] 得られたサリチル酸エステル 0. 25gをエタノール 30ml〖こ溶解し、水 20ml、水酸化 ナトリウム 0. 5gを加えて 3時間 50°Cで加熱を行った。反応終了後、反応液に希塩酸 をカロえ中性にした後、クロ口ホルムを使用して抽出処理を行った。有機層を水、飽和 食塩水で順次洗浄した後、無水硫酸ナトリウムで乾燥した。溶媒を留去し、クロ口ホル ムーメタノールで再結晶して目的化合物 0. 15gを得た。この化合物の物性を表 5に示 す。 [0033] 0.25 g of the obtained salicylate was dissolved in 30 ml of ethanol, 20 ml of water and 0.5 g of sodium hydroxide were added, and the mixture was heated at 50 ° C for 3 hours. After completion of the reaction, the reaction solution was neutralized with dilute hydrochloric acid, and then subjected to an extraction treatment using black form. The organic layer was washed sequentially with water and saturated saline, and then dried over anhydrous sodium sulfate. The solvent was distilled off and recrystallized from chloroform-form methanol to obtain 0.15 g of the desired compound. Table 5 shows the physical properties of this compound.
[0034] [表 5]  [0034] [Table 5]
(1)融点: 235〜236°C (1) Melting point: 235-236 ° C
(2) IR(NaCl法, ,cm- : 1654' 1620, 1604, 1464, 1244, 1108  (2) IR (NaCl method,, cm-: 1654 '1620, 1604, 1464, 1244, 1108
(3) NMR(CDC13, δ ,ppm): 5.19(2H,s),6.53(lH,d,J=8.0Hz),6.70(lH,d,J=8.0Hz),  (3) NMR (CDC13, δ, ppm): 5.19 (2H, s), 6.53 (lH, d, J = 8.0 Hz), 6.70 (lH, d, J = 8.0 Hz),
7.42(lH,t,J=8.0Hz), 7.5(2H,bs),11.2(lH,bs)  7.42 (lH, t, J = 8.0Hz), 7.5 (2H, bs), 11.2 (lH, bs)
[0035] 上記製造例 1一 3に準じた操作で、下記表 6— 7の化合物を合成した。これらの化 合物の融点および NMRデータを表 6— 7に示す。 [0035] The compounds shown in Tables 6 to 7 below were synthesized by operations according to Production Examples 13 to 13 described above. The melting points and NMR data of these compounds are shown in Tables 6-7.
[0036] [表 6] [Table 6]
Figure imgf000014_0001
Figure imgf000014_0001
Figure imgf000014_0002
Figure imgf000014_0002
ZY 0..CZ0/S00Z OAV ぐ ¾氺> ZY 0..CZ0 / S00Z OAV ぐ
■z m [6εοο]  ■ z m [6εοο]
<隨>
Figure imgf000015_0001
<Skill>
Figure imgf000015_0001
Figure imgf000015_0002
izLzio/toozdr/Ud 0..CZ0/S00Z OAV 本発明化合物 (ィ匕合物番号 Π-3) 50重量部とリグ-ンスルホン酸塩 5重量部とアル キルスルホン酸塩 3重量部と珪藻土 42重量部とを粉砕混合して水和剤とし、水で希 釈して使用する。
Figure imgf000015_0002
izLzio / toozdr / Ud 0..CZ0 / S00Z OAV 50 parts by weight of the compound of the present invention (I-Danied Compound No. III-3), 5 parts by weight of lignesulfonate, 3 parts by weight of alkylsulfonate and 42 parts by weight of diatomaceous earth were mixed by pulverization to obtain a wettable powder. Use it after dilution.
[0040] 製剤例 3 : [0040] Formulation Example 3:
<粒剤>  <Granules>
本発明化合物 (ィ匕合物番号 Π— 7) 5重量部とベンナイト 43重量部とクレー 45重量部 とリグ-ンスルホン酸塩 7重量部とを均一に混合しさらに水をカ卩えて練り合わせ、押し 出し式造粒機で粒状に加工乾燥して粒剤とする。  5 parts by weight of the compound of the present invention (I-Danied Compound No. Π-7), 43 parts by weight of benite, 45 parts by weight of clay and 7 parts by weight of lignesulfonate are uniformly mixed, and the mixture is kneaded by kneading with water. It is processed into granules by a dispensing granulator and dried to obtain granules.
[0041] 製剤例 4 : Formulation Example 4:
<乳剤 >  <Emulsion>
本発明化合物(ィ匕合物番号 Π— 10) 20重量部とポリオキシエチレンアルキルァリー ルエーテル 10重量部とポリオキシエチレンソルビタンモノラウレート 3重量部とキシレ ン 67重量部とを均一に混合溶解して乳剤とする。  20 parts by weight of the compound of the present invention (I-Ridant No. Π-10), 10 parts by weight of polyoxyethylene alkyl aryl ether, 3 parts by weight of polyoxyethylene sorbitan monolaurate and 67 parts by weight of xylene are uniformly mixed and dissolved. To obtain an emulsion.
[0042] 試験例 1 :  Test example 1:
<イネいもち病防除効果試験 (水面施用) >  <Rice blast control effect test (water application)>
水田土を詰めた 1/ 1 OOOOaワグネルポットに 3葉期のイネ(品種:コシヒカリ)を移植 し 20— 35日後、製剤例 3に準じて調整した粒剤を所定濃度(500g/10a)となる様に 水面施用した。薬剤処理 10— 20日後に、イネ罹病上で形成させたイネいもち病菌 の胞子懸濁液を噴霧接種し、ガラス温室内のビニールトンネル内で高湿度下に保つ た。接種力も 10— 20日後に発病面積率(%)を達観で調査し、下記表 8の調査基準 (中国農試葉いもち調査基準)により、発病度を一試験区あたり全苗について調査し 、 1ポット当たりの平均発病度から計算式:防除価 = (1 -処理区発病度 Z無処理区 発病度) X 100により防除価(%)を算出した。結果を表 9に示す。  Transplant rice (variety: Koshihikari) at the 3 leaf stage into a 1/1 OoWa Wagner pot filled with paddy soil, and after 20 to 35 days, the granules adjusted according to Formulation Example 3 have a predetermined concentration (500 g / 10a) Was applied to the water surface in the same manner. 10 to 20 days after the chemical treatment, a spore suspension of the rice blast fungus formed on the rice disease was sprayed and inoculated, and kept under high humidity in a vinyl tunnel in a glass greenhouse. After 10-20 days, the inoculation power was examined arbitrarily for the diseased area rate (%), and the disease incidence was investigated for all seedlings per test plot according to the survey criteria shown in Table 8 below (Chinese agricultural test blast criterion). The control value (%) was calculated from the average disease rate per pot using the following formula: control value = (1-disease rate in treated area Z disease rate in untreated area) x 100. Table 9 shows the results.
[0043] [表 8] 発病度 発病面積率 (%) [Table 8] Disease severity Disease area rate (%)
0 0  0 0
1 0を超え 0. 5未満 More than 10 and less than 0.5
2 0. 5以上 1未満2 0.5 or more and less than 1
3 1以上 2未満 3 1 or more and less than 2
4 2以上 5未満  4 2 or more and less than 5
5 5以上 10未満 5 5 or more and less than 10
6 10以上 25未満6 10 or more and less than 25
7 25以上 50未満7 25 or more and less than 50
8 50以上 80未満8 50 or more and less than 80
9 80以上 100未満9 80 or more and less than 100
10 枯死 10 Withering
[0044] [表 9] [Table 9]
Figure imgf000017_0001
Figure imgf000017_0001
[0045] 試験例 2: <コムギうどんこ病防除効果 (茎葉散布) > [0045] Test example 2: <Effect of controlling wheat powdery mildew (foliage application)>
角型ポット(1. 5cm X 2. Ocm)を用いて、分げつ期温室内で栽培したコムギ(品種 :農林 61号)に、製剤例 2に準じて調製した水和剤を所定濃度(125g/ha)に水で希 釈懸濁し、 lOOOL/haの割合で散布した。薬剤処理 10— 20日後、コムギうどんこ病 の胞子をふりかけ接種した。その後、ガラス温室内で発病させた。接種後 10— 20日 目に発病面積率 (%)を達観で調査し、下記表 10の調査基準により、 1ポット当たりの 平均発病度から計算式:防除価 = (1 -処理区発病度 Z無処理区発病度) X 100に より防除価 (%)を算出した。結果を表 11に示す。  Using a square pot (1.5 cm X 2. Ocm), wheat (cultivar: Norin 61) cultivated in a greenhouse at the tillering stage was mixed with a wettable powder prepared according to Formulation Example 2 at a specified concentration ( The suspension was diluted with water at 125 g / ha) and sprayed at a rate of 100 L / ha. 10 to 20 days after drug treatment, spores of wheat powdery mildew were sprinkled and inoculated. Thereafter, the disease was caused in a glass greenhouse. 10 to 20 days after the inoculation, the disease area rate (%) is examined arbitrarily. Based on the survey criteria in Table 10 below, the formula is calculated from the average disease rate per pot: control value = (1-treatment area disease rate Z The control value (%) was calculated by X100. Table 11 shows the results.
[0046] [表 10] [Table 10]
Figure imgf000018_0001
Figure imgf000018_0001
[0047] [表 11] [Table 11]
■f匕合物番^ ^ 化合物番号 防除価■ f danger compound number ^ ^ compound number
II一 1 65 85II-I 1 65 85
II一 2 90 11-15 85II-II 2 90 11-15 85
II一 3 85 11— 16 75 II-I 3 85 11— 16 75
(D 11— 17 90 (D 11— 17 90
II ο o 11— 18II ο o 11—18
Figure imgf000019_0001
ίυ o「
Figure imgf000019_0001
ίυ o
II一 7 80 11-20 75 cII-I 7 80 11-20 75 c
II一 8 75 65II 1 8 75 65
II 9 60 11-22 90II 9 60 11-22 90
II 10 75 11-23 70 II 10 75 11-23 70
95 95 95 95
II- 12 80 1-1 75II- 12 80 1-1 75
11-13 85 1-2寸 70 11-13 85 1-2 inch 70

Claims

請求の範囲 [1] 下記の式 (ι·π)のサリチル酸誘導体またはその塩を有効成分として含有する農園 芸用病害防除剤。 Claims [1] An agricultural and horticultural disease controlling agent comprising a salicylic acid derivative of the following formula (ι · π) or a salt thereof as an active ingredient.
[化 1]  [Chemical 1]
Figure imgf000020_0001
Figure imgf000020_0001
(式中、 Xは、低級アルキル基、低級アルコキシ基、低級ハロアルキル基またはハロゲ ン原子を表し、 mは 0から 3の整数を表す。 mが 2以上の時は、 Xは同一もしくは異な つていてもよい。 R1は、水素原子または低級アルキル基を表し、 R2は、水素原子、水 酸基、ハロゲン原子、ジメチルァミノ基、低級アルキル基または低級ハロアルキル基 を表す。) (In the formula, X represents a lower alkyl group, a lower alkoxy group, a lower haloalkyl group or a halogen atom, and m represents an integer of 0 to 3. When m is 2 or more, X is the same or different. R 1 represents a hydrogen atom or a lower alkyl group, and R 2 represents a hydrogen atom, a hydroxyl group, a halogen atom, a dimethylamino group, a lower alkyl group or a lower haloalkyl group.)
[2] 下記の式 (III)の 2-ヒドロキシ安息香酸誘導体と式 (IV)の置換ベンジルノ、ライドと を反応させることを特徴とする、式 (Π)のサリチル酸エステルの製造方法。  [2] A method for producing a salicylic acid ester of the formula (II), which comprises reacting a 2-hydroxybenzoic acid derivative of the following formula (III) with a substituted benzylno or ride of the formula (IV).
[化 2] [Chemical 2]
Figure imgf000021_0001
Figure imgf000021_0001
(式中、 Xは、低級アルキル基、低級アルコキシ基、低級ハロアルキル基またはハロゲ ン原子を表し、 mは 0から 3の整数を表す。 mが 2以上の時には、 Xは同一もしくは異 なっていてもよい。 Rは、低級アルキル基を表し、 R2は、水素原子、水酸基、ハロゲン 原子、ジメチルァミノ基、低級アルキル基または低級ハロアルキル基を表し、 Yは、ハ ロゲン原子を表す。 ) (In the formula, X represents a lower alkyl group, a lower alkoxy group, a lower haloalkyl group or a halogen atom, and m represents an integer of 0 to 3. When m is 2 or more, X is the same or different. R represents a lower alkyl group, R 2 represents a hydrogen atom, a hydroxyl group, a halogen atom, a dimethylamino group, a lower alkyl group or a lower haloalkyl group, and Y represents a halogen atom.)
[3] 下記の式 (Ι·Π)で表されるサリチル酸誘導体またはその塩。  [3] A salicylic acid derivative represented by the following formula (Ι · Π) or a salt thereof.
[化 3]  [Formula 3]
Figure imgf000021_0002
Figure imgf000021_0002
(式中、 Xは、低級アルキル基、低級アルコキシ基、低級ハロアルキル基またはハロゲ ン原子を表し、 mは 0から 3の整数を表す。 mが 2以上の時は、 Xは同一もしくは異な つていてもよい。 R1は、水素原子または低級アルキル基を表し、 R2は、水素原子、水 酸基、ハロゲン原子、ジメチルァミノ基、低級アルキル基または低級ハロアルキル基 を表す。) (In the formula, X is a lower alkyl group, a lower alkoxy group, a lower haloalkyl group or a halogeno group. And m represents an integer of 0 to 3. When m is 2 or more, X may be the same or different. R 1 represents a hydrogen atom or a lower alkyl group; R 2 represents a hydrogen atom, a hydroxyl group, a halogen atom, a dimethylamino group, a lower alkyl group or a lower haloalkyl group. )
PCT/JP2004/012721 2003-09-04 2004-09-02 Salicylic acid derivatives, process for production thereof and disease controllers for agricultural and horticultural use WO2005023770A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005513659A JP4655932B2 (en) 2003-09-04 2004-09-02 Salicylic acid derivative, its production method and agricultural and horticultural disease control agent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003312701 2003-09-04
JP2003-312701 2003-09-04

Publications (1)

Publication Number Publication Date
WO2005023770A1 true WO2005023770A1 (en) 2005-03-17

Family

ID=34269746

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2004/012721 WO2005023770A1 (en) 2003-09-04 2004-09-02 Salicylic acid derivatives, process for production thereof and disease controllers for agricultural and horticultural use

Country Status (2)

Country Link
JP (1) JP4655932B2 (en)
WO (1) WO2005023770A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992019603A1 (en) * 1991-04-30 1992-11-12 Mitsubishi Petrochemical Co., Ltd. Phenoxymethylpyrimidine derivative and use thereof as herbicide
JPH08291110A (en) * 1995-04-21 1996-11-05 Kureha Chem Ind Co Ltd Salicylic acid derivative, its production and agricultural and horticultural fungicide
JPH1029961A (en) * 1996-07-12 1998-02-03 Kureha Chem Ind Co Ltd Salicylic acid derivative, is production and agricultural and horticultural fungicide
WO1999012910A1 (en) * 1997-09-11 1999-03-18 Nissan Chemical Industries, Ltd. Pyrazole compounds and plant disease control agent
JPH11171864A (en) * 1997-09-10 1999-06-29 Dainippon Ink & Chem Inc 2,6-dichloro-4-pyridinemethanol derivative and agrochemical

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147274A (en) * 1962-05-24 1964-09-01 Dow Chemical Co Anisic acid derivatives of benzimidazoles

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992019603A1 (en) * 1991-04-30 1992-11-12 Mitsubishi Petrochemical Co., Ltd. Phenoxymethylpyrimidine derivative and use thereof as herbicide
JPH08291110A (en) * 1995-04-21 1996-11-05 Kureha Chem Ind Co Ltd Salicylic acid derivative, its production and agricultural and horticultural fungicide
JPH1029961A (en) * 1996-07-12 1998-02-03 Kureha Chem Ind Co Ltd Salicylic acid derivative, is production and agricultural and horticultural fungicide
JPH11171864A (en) * 1997-09-10 1999-06-29 Dainippon Ink & Chem Inc 2,6-dichloro-4-pyridinemethanol derivative and agrochemical
WO1999012910A1 (en) * 1997-09-11 1999-03-18 Nissan Chemical Industries, Ltd. Pyrazole compounds and plant disease control agent

Also Published As

Publication number Publication date
JP4655932B2 (en) 2011-03-23
JPWO2005023770A1 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
JP5089581B2 (en) 1,2-Benzisothiazole derivatives and plant disease control agents for agriculture and horticulture
US20170226078A1 (en) Processes for the preparation of pesticidal compounds
JP4706482B2 (en) Pyridylmethyl derivative of 2,6-dichloroisonicotinic acid, method for producing the same, and agricultural and horticultural disease control agent
NZ518452A (en) Oxime O-ether compounds and fungicides for agricultural and horticultural use
JP3805405B2 (en) Salicylic acid derivative, method for producing the same, and agricultural and horticultural fungicide
EP0658547B1 (en) N-pyrazolyl carbamate derivative, agricultural/horticultural fungicide containing the same as active ingredient and production intermediate thereof
JPH09268169A (en) Salicylic acid anilide derivative and controlling agent for plant disease injury containing the same derivative as active ingredient
WO2005023770A1 (en) Salicylic acid derivatives, process for production thereof and disease controllers for agricultural and horticultural use
JP4534452B2 (en) 3-methylisothiazole-5-methanol derivative, process for producing the same, and agricultural and horticultural disease control
JPH0822853B2 (en) Pyrazole-4-carboxylic acids and method for producing the same
JP3981771B2 (en) 2-Benzyloxy-6-alkoxybenzoic acid derivative, method for producing the same, and agricultural and horticultural fungicide
JP2000159610A (en) Plant disease control agent for agriculture and horticulture and new isooxazole carboxylic acid derivative
JP4561068B2 (en) 2-Chloro-1,3-thiazole-5-methanol derivative, process for producing the same and agricultural and horticultural disease control agent
JP2007137852A (en) Azine derivative and agricultural/horticultural fungicide
JP3822678B2 (en) Salicylic acid derivative, method for producing the same, and agricultural and horticultural fungicide
JPH0768220B2 (en) Novel pyrazole derivative, production method thereof, and agricultural / horticultural fungicide containing them
JP4484308B2 (en) Benzoxazole derivative, process for producing the same and herbicide
JP2010006722A (en) Pyridazine derivative and fungicide
KR900003390B1 (en) Pyrazol derivatives and agricultural and horticultural fungicides containing said compounds
JP4906084B2 (en) 2,6-dichloro-4-cyclic aminomethylpyridine derivative, acid addition salt thereof, method for producing the same, and agricultural and horticultural disease control agent
JP5016760B2 (en) Benzoxazole derivatives, process for producing them and herbicides
CN116253727A (en) Piperidine amide compound containing trifluoromethyl oxadiazole biphenyl, preparation method and application thereof
JPH0912551A (en) Iminothioether-based compound, its production and intermediate thereof and germicide/miticide
CN116253728A (en) Piperidine amide compound containing trifluoromethyl oxadiazole dithiophene, and preparation method and application thereof
CN118221605A (en) Isoxazoline-containing compound, preparation method and application thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2005513659

Country of ref document: JP

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase